Andrew Catchpole
Technik-/Wissenschafts-/F&E-Leiter bei HVIVO PLC
Ursprung des Netzwerks ersten Grades von Andrew Catchpole
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
hVIVO Services Ltd.
hVIVO Services Ltd. Internet Software/ServicesTechnology Services Part of hVIVO PLC, hVIVO Services Ltd. is a British company that specializes in full-service viral challenge studies. The company is based in London, UK. The company's services include challenge models and lab services. The company was founded in 1988 by John Sidney Oxford.
15
| Subsidiary | Internet Software/Services | 15 |
13
| Subsidiary | Miscellaneous Commercial Services | 13 |
11
| Public Company | Miscellaneous Commercial Services | 11 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Andrew Catchpole
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
AFFYMETRIX, INC. | Medical Specialties | Corporate Officer/Principal | |
1-800 Contacts, Inc.
1-800 Contacts, Inc. Specialty StoresRetail Trade 1-800 Contacts, Inc. retails and sells contact lenses. Its products include disposable contact lenses, toric, color, bifocal lenses and accessories. The firm offers all brands of contact lenses and also offers eyeglasses and sunglasses. The company was founded by Jonathan C. Coon and John F. Nichols in 1995 and is headquartered in Orem, UT. | Specialty Stores | Director of Finance/CFO | |
The British Pain Society
The British Pain Society Miscellaneous Commercial ServicesCommercial Services The British Pain Society operates as a multidisciplinary professional organization in the field of pain. It produces contemporary guidance, supported by available evidence on clinical and other pain matters. The company was Incorporated on November 29, 1979 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Equipment/Instruments | Chairman Founder | |
IXICO PLC | Miscellaneous Commercial Services | Director/Board Member | |
FEEDBACK PLC | Packaged Software | Director of Finance/CFO | |
University of Oxford | College/University | Undergraduate Degree Undergraduate Degree | |
IP GROUP PLC | Miscellaneous Commercial Services | Founder Corporate Officer/Principal Director/Board Member | |
University of Cambridge | College/University | Undergraduate Degree | |
Receptor Research Ltd.
Receptor Research Ltd. Chemicals: Major DiversifiedProcess Industries Part of Tripos, Inc., Receptor Research Ltd. provides drug discovery informatics products and services. The company is based in Bude, UK. Receptor Research was acquired by Tripos, Inc. on November 18, 1997. | Chemicals: Major Diversified | Corporate Officer/Principal | |
The Royal Society of Chemistry
The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services The Royal Society of Chemistry is an organization that supports the chemical sciences community in making the world a better place. The Royal Society of Chemistry is based in London, UK, and has subsidiaries in the United Kingdom. The British company offers various opportunities in education, inclusion, and chemistry's ability to tackle challenges. The organization aims to advance excellence, connect chemical scientists, and shape the future of the chemical sciences for the benefit of humanity. The private company has a publishing portfolio that contains over one million articles, chapters, and records from across the chemical sciences and related fields. The company also provides solutions to help businesses engage with their audience of chemical scientists. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
SANTHERA PHARMACEUTICALS HOLDING AG | Pharmaceuticals: Major | Director of Finance/CFO | |
University of Bristol | College/University | Undergraduate Degree Doctorate Degree | |
Trinity College Dublin | College/University | Undergraduate Degree Undergraduate Degree | |
University of Durham | College/University | Doctorate Degree | |
ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
Chartered Institute of Personnel & Development | College/University | Corporate Officer/Principal | |
Liverpool John Moores University | College/University | Undergraduate Degree | |
Sucampo Pharma Europe Ltd.
Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mallinckrodt Plc, Sucampo Pharma Europe Ltd. is a British company that develops therapies for gastrointestinal, circulatory, and ophthalmic diseases. The company is based in London, UK. Sucampo Pharma Europe was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on September 28, 2006. | Miscellaneous Commercial Services | Director of Finance/CFO | |
DEEPMATTER GROUP PLC | Packaged Software | Director/Board Member Chief Executive Officer | |
Sucampo GmbH
Sucampo GmbH Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Sucampo GmbH is a Swiss company that manufactures and distributes pharmaceuticals and health care products. The company is based in Zug, Switzerland. The company was founded by Ryuji Ueno, Sachiko Kuno. Sucampo was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on December 29, 2010 for $120 million. | Pharmaceuticals: Major | Director of Finance/CFO | |
NYKODE THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
Clearlab Europe Ltd. | Founder | ||
Azellon Ltd.
Azellon Ltd. Miscellaneous Commercial ServicesCommercial Services Azellon Ltd. develops stem cell therapy for the repair of avascular meniscal tears. The firm's meniscal repair technology combines bone marrow stem cells with a special membrane that helps to deliver the cells into the injured site. The company was founded by Anthony Hollander and Troels Jordansen in 2007 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Iksuda Therapeutics Ltd.
Iksuda Therapeutics Ltd. BiotechnologyHealth Technology Iksuda Therapeutics Ltd. operates as a biotechnology company which specializes in the development of next generation biotherapeutics. It creates new generation biological therapeutics through advanced glycosylation and conjugation technologies. The company has core expertise in protein/peptide fictionalization and glycosylation technologies, imparting improved pharmacokinetic properties to a broader range of biological therapeutics. It was founded by David John Simpson and Andrew Watts on November 21, 2007 and is headquartered in Newcastle upon Tyne, the United Kingdom. | Biotechnology | Director/Board Member | |
Activiomics Ltd.
Activiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Activiomics Ltd. develops innovative technologies that utilize mass spectrometry to interrogate and interpret the activity of cellular signaling pathways. It offers phosphoproteomics for biomaker discovery and drug profiling. The company was founded by Bart Vanhaesebroeck and Pedro Rodriguez Cutillas in 2009 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Chief Executive Officer | |
Raglan Capital Ltd.
Raglan Capital Ltd. Investment ManagersFinance Raglan Capital Ltd. is an Irish company that specializes in creating in-house companies for rapid listing on the London Stock Exchange. Raglan Capital aims to create one new company per year and achieve an IPO within three years. The private company has offices in Ireland, the UK, and the US. The company's portfolio includes companies such as Poolbeg Pharma, HVIVO, Amryt Pharma, Fastnet Oil & Gas, and European Green Metals. The company was founded in 2007 by Cathal Martin Friel, who has been the CEO since incorporation. | Investment Managers | Chief Executive Officer | |
IP Group Plc /Venture Capital/
IP Group Plc /Venture Capital/ Investment ManagersFinance IP Group Plc /Venture Capital/ (IP Group) is a venture capital subsidiary of IP Group Plc founded in 2001. The firm is headquartered in London, United Kingdom. | Investment Managers | Director/Board Member | |
Allecra Therapeutics GmbH
Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Allecra Therapeutics GmbH focuses on the development of novel treatments to combat multi drug-resistant bacterial infections. The firm serves the bio and pharmaceutical industry. The company was founded by Nicholas Benedict and Stuart Shapiro in 2013 and is headquartered in Weil am Rhein, Germany. | Pharmaceuticals: Major | Director of Finance/CFO | |
T5 Oil & Gas Ltd.
T5 Oil & Gas Ltd. Oil & Gas ProductionEnergy Minerals T5 Oil & Gas Ltd. explores oil and gas resources. The firm develops portfolio of conventional oil and gas resources. The company was incorporated by Patrick Joseph Plunkett, Gerry Sheehan, Matthew O'Donoghue, Andrew Guy Windham and Stephen James McTiernan on August 07, 2013 and is headquartered in London, the United Kingdom. | Oil & Gas Production | Director/Board Member | |
Genomics Plc
Genomics Plc BiotechnologyHealth Technology Genomics Plc develops research and experimental development on biotechnology. It develops and applies cutting edge analysis and algorithms to database of genomic and phenotypic data to uncover the relationships between genetic variation and human disease. The company was founded by Peter Donnely, Gil McVean, Chris Spencer and Gerton Lunter on January 10, 2004 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Founder | |
ARIX BIOSCIENCE PLC | Investment Managers | Director/Board Member | |
Santhera Pharmaceuticals (USA), Inc.
Santhera Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Santhera Pharmaceuticals (USA), Inc. engages in the provision of regulatory and medical services. The company is headquartered in Burlington, MA. | Pharmaceuticals: Major | Director/Board Member | |
Open Orphan DAC
Open Orphan DAC Packaged SoftwareTechnology Services Open Orphan DAC develops platform for pharmaceutical and biotechnology companies seeking to commercialize their products across Europe. It focuses on building its database of over 500 pharmaceutical companies with orphan drugs either approved or advancing through clinical trials. The company is headquartered in Ballsbridge, Ireland. | Packaged Software | Chief Executive Officer Chairman | |
Imutex Ltd.
Imutex Ltd. BiotechnologyHealth Technology Imutex Ltd. is a British company that develops vaccines. The joint venture company is based in London, UK. | Biotechnology | Director/Board Member Director/Board Member | |
POOLBEG PHARMA PLC | Pharmaceuticals: Major | Founder Director/Board Member Director of Finance/CFO General Counsel | |
Keltic Pharma Therapeutics Ltd.
Keltic Pharma Therapeutics Ltd. BiotechnologyHealth Technology Keltic Pharma Therapeutics Ltd. is an Irish private company. The firm engages in drug discovery programs. | Biotechnology | Chief Executive Officer | |
Angelini Ventures SpA
Angelini Ventures SpA Investment ManagersFinance Angelini Ventures SpA (Angelini Ventures) is a venture capital firm founded in 2022. The firm is headquartered in Rome, Italy. | Investment Managers | Consultant / Advisor | |
Arix Bioscience /Venture Capital/
Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience /Venture Capital/ (Arix Bioscience) is a venture capital subsidiary of Arix Bioscience Plc founded in 2015 by Christopher Thomas Evans, Jonathan M. Peacock and Joseph Anderson. The firm is headquartered in London, United Kingdom with an additional offices in New York. | Investment Managers | Director/Board Member | |
DegraSense Ltd. | Director/Board Member | ||
Ubiquigent Ltd.
Ubiquigent Ltd. Miscellaneous Commercial ServicesCommercial Services Ubiquigent Ltd. develops reagents, kits, drug discovery assay development and compound profiling services to the academic and commercial life science research community worldwide. It focus; namely the ubiquitin, ubiquitin-like and integrated signalling systems. The company has established its scientific and business credentials with both academic researchers undertaking fundamental scientific discovery as well as with pharmaceutical and biotechnology company scientists undertaking ubiquitin system-focused drug discovery. Ubiquigent was founded by Jason Brown in 2009 and is headquartered in Dundee, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
Vereinigtes Königreich | 35 |
Irland | 6 |
Vereinigte Staaten | 5 |
Schweiz | 3 |
Dänemark | 2 |
Sektoral
Health Technology | 16 |
Commercial Services | 11 |
Finance | 8 |
Consumer Services | 7 |
Technology Services | 5 |
Operativ
Director/Board Member | 98 |
Corporate Officer/Principal | 41 |
Founder | 26 |
Director of Finance/CFO | 25 |
Chairman | 24 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
David Robert Norwood | 22 |
Trevor Phillips | 20 |
Mark Robert Warne | 19 |
Trevor Nicholls | 19 |
Brendan Buckley | 16 |
Elaine Sullivan | 15 |
Andrew P. Smith | 14 |
Cathal Friel | 13 |
Martin Gouldstone | 12 |
Leo Toole | 10 |
Graham Edward Yeatman | 8 |
Yamin Khan | 5 |
Kym Lynn Denny | 5 |
Aneshkumar Patel | 4 |
Ian O'Connell | 3 |
- Börse
- Insiders
- Andrew Catchpole
- Unternehmensverbindungen